IL6 and COVID-19: However, several other studies suggested that immunosuppressants may be beneficial to patients infected with COVID-19 by mitigating cytokine storms, such as anti-interleukin (IL)-6 antibodies [9] and anti-tumor necrosis factor (TNF) therapy [10].